These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22045660)

  • 1. An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH.
    Koh AJ; Novince CM; Li X; Wang T; Taichman RS; McCauley LK
    Endocrinology; 2011 Dec; 152(12):4525-36. PubMed ID: 22045660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6.
    Pirih FQ; Michalski MN; Cho SW; Koh AJ; Berry JE; Ghaname E; Kamarajan P; Bonnelye E; Ross CW; Kapila YL; Jurdic P; McCauley LK
    PLoS One; 2010 Oct; 5(10):e13657. PubMed ID: 21048959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone.
    Cho SW; Pirih FQ; Koh AJ; Michalski M; Eber MR; Ritchie K; Sinder B; Oh S; Al-Dujaili SA; Lee J; Kozloff K; Danciu T; Wronski TJ; McCauley LK
    J Biol Chem; 2013 Mar; 288(10):6814-25. PubMed ID: 23297399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nmp4/CIZ suppresses the parathyroid hormone anabolic window by restricting mesenchymal stem cell and osteoprogenitor frequency.
    He Y; Childress P; Hood M; Alvarez M; Kacena MA; Hanlon M; McKee B; Bidwell JP; Yang FC
    Stem Cells Dev; 2013 Feb; 22(3):492-500. PubMed ID: 22873745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.
    Novince CM; Koh AJ; Michalski MN; Marchesan JT; Wang J; Jung Y; Berry JE; Eber MR; Rosol TJ; Taichman RS; McCauley LK
    Am J Pathol; 2011 Nov; 179(5):2431-42. PubMed ID: 21939632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
    Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
    J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.
    Novince CM; Michalski MN; Koh AJ; Sinder BP; Entezami P; Eber MR; Pettway GJ; Rosol TJ; Wronski TJ; Kozloff KM; McCauley LK
    J Bone Miner Res; 2012 Jan; 27(1):11-25. PubMed ID: 21932346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.
    Koh AJ; Demiralp B; Neiva KG; Hooten J; Nohutcu RM; Shim H; Datta NS; Taichman RS; McCauley LK
    Endocrinology; 2005 Nov; 146(11):4584-96. PubMed ID: 16081645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow.
    Jacome-Galarza CE; Lee SK; Lorenzo JA; Aguila HL
    J Bone Miner Res; 2011 Jun; 26(6):1207-16. PubMed ID: 21611963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bone marrow stromal cells in irradiation leukemogenesis.
    Greenberger JS; Epperly MW; Jahroudi N; Pogue-Geile KL; Berry L; Bray J; Goltry KL
    Acta Haematol; 1996; 96(1):1-15. PubMed ID: 8677755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
    Tanaka S; Sakai A; Tanaka M; Otomo H; Okimoto N; Sakata T; Nakamura T
    J Bone Miner Res; 2004 Nov; 19(11):1813-20. PubMed ID: 15476581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor hematopoietic stem cells confer long-term marrow reconstitution by self-renewal divisions exceeding to that of host cells.
    Roy S; Javed S; Jain SK; Majumdar SS; Mukhopadhyay A
    PLoS One; 2012; 7(12):e50693. PubMed ID: 23227199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
    Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
    PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment.
    Stanislaus D; Yang X; Liang JD; Wolfe J; Cain RL; Onyia JE; Falla N; Marder P; Bidwell JP; Queener SW; Hock JM
    Bone; 2000 Aug; 27(2):209-18. PubMed ID: 10913913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTH and stem cells.
    Ohishi M; Schipani E
    J Endocrinol Invest; 2011; 34(7):552-6. PubMed ID: 21427529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone.
    Yamashita J; Datta NS; Chun YH; Yang DY; Carey AA; Kreider JM; Goldstein SA; McCauley LK
    J Bone Miner Res; 2008 May; 23(5):621-32. PubMed ID: 18086008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.